BindingDB logo
myBDB logout

50 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
27977181 8 An Orally Active Bradykinin BEBI Nanyang Technological University
23403082 28 Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.EBI Broad Institute of MIT and Harvard
22369198 40 From bradykinin B2 receptor antagonists to orally active and selective bradykinin B1 receptor antagonists.EBI Laboratoires Fournier
22342268 98 Design and synthesis of novel sulfonamide-containing bradykinin hB(2) receptor antagonists. Synthesis and structure-relationships ofa,a-tetrahydropyranylglycine.EBI Menarini Ricerche
8691478 25 Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.EBI Cortech, Inc.
21413808 170 Synopsis of some recent tactical application of bioisosteres in drug design.EBI Bristol-Myers Squibb Pharmaceutical Research and Development
21571530 62 Discovery of a potent and selective small molecule hGPR91 antagonist.EBI Advinus Therapeutics
22483585 28 Quinolinyl- and phenantridinyl-acetamides as bradykinin B1 receptor antagonists.EBI Gedeon Richter Plc.
18553956 38 2-Aminobenzophenones as a novel class of bradykinin B1 receptor antagonists.EBI Merck Research Laboratories
18240388 19 A new class of bradykinin B1 receptor antagonists with high oral bioavailability and minimal PXR activity.EBI Merck Research Laboratories
18061443 34 Alpha-hydroxy amides as a novel class of bradykinin B1 selective antagonists.EBI Merck Research Laboratories
12723943 29 Benzodiazepines as potent and selective bradykinin B1 antagonists.EBI Merck Research Laboratories
10514288 12 Design and synthesis of potent bradykinin agonists containing a benzothiazepine moiety.EBI Universit£s Montpellier I et II
22197141 64 Discovery of dehydro-oxopiperazine acetamides as novel bradykinin B1 receptor antagonists with enhanced in vitro potency.EBI Amgen, Inc.
22088753 44 Chromenones as potent bradykinin B1 antagonists.EBI Amgen Inc.
21902230 49 Discovery of potent, orally bioavailable phthalazinone bradykinin B1 receptor antagonists.EBI Amgen Inc.
21615150 14 Progress in structure based drug design for G protein-coupled receptors.EBI Heptares Therapeutics Limited
21514825 81 3-Oxo-2-piperazinyl acetamides as potent bradykinin B1 receptor antagonists for the treatment of pain and inflammation.EBI Amgen, Inc.
20369879 21 Bradykinin B1 receptor antagonists as potential therapeutic agents for pain.EBI Johnson& Johnson Pharmaceutical Research and Development
20813948 63 Spiroindolones, a potent compound class for the treatment of malaria.EBI Swiss Tropical and Public Health Institute
20573508 31 Aryl sulfonamides containing tetralin allylic amines as potent and selective bradykinin B1 receptor antagonists.EBI Amgen Inc.
20036120 16 Novel small molecule bradykinin B1 receptor antagonists. Part 3: hydroxyurea derivatives.EBI Jerini AG
20015651 16 Novel small molecule bradykinin B1 receptor antagonists. Part 2: 5-membered diaminoheterocycles.EBI Jerini AG
20015645 24 Novel small molecule bradykinin B1 receptor antagonists. Part 1: benzamides and semicarbazides.EBI Jerini AG
19014884 18 Sulfonamido-aryl ethers as bradykinin B1 receptor antagonists.EBI Pharmacopeia Inc
18752949 60 1-Benzylbenzimidazoles: the discovery of a novel series of bradykinin B(1) receptor antagonists.EBI Neurogen Corporation
18722115 11 Bradykinin B1 receptor antagonists: an alpha-hydroxy amide with an improved metabolism profile.EBI Merck
18706809 45 Aryl sulfones as novel bradykinin B1 receptor antagonists for treatment of chronic pain.EBI Amgen Inc.
18674903 32 Discovery of dihydroquinoxalinone acetamides containing bicyclic amines as potent Bradykinin B1 receptor antagonists.EBI Amgen Inc.
18068274 2 Novel bradykinin-1 antagonists containing a (1,2,3,4-tetrahydro-isoquinolin-1-yl)acetic acid scaffold.EBI University of Szeged
17880055 42 Preparation and optimization of a series of 3-carboxamido-5-phenacylaminopyrazole bradykinin B1 receptor antagonists.EBI Elan Pharmaceuticals, Inc.
17482459 17 Bradykinin B1 antagonists: biphenyl SAR studies in the cyclopropanecarboxamide series.EBI Merck
17428657 18 Potent bradykinin B1 receptor antagonists: 4-substituted phenyl cyclohexanes.EBI Merck
17408249 76 Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides.EBI Amgen Inc.
17243660 42 Identification of a nonpeptidic and conformationally restricted bradykinin B1 receptor antagonist with anti-inflammatory activity.EBI Amgen Inc.
17228869 44 Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists.EBI Merck Research Laboratories
16529929 55 5-Piperazinyl pyridine carboxamide bradykinin B1 antagonists.EBI Merck Research Laboratories
16480259 22 Cyclopropylamino acid amide as a pharmacophoric replacement for 2,3-diaminopyridine. Application to the design of novel bradykinin B1 receptor antagonists.EBI TBA
16464576 56 A new class of bradykinin 1 receptor antagonists containing the piperidine acetic acid tetralin core.EBI Amgen Inc.
15993596 23 Bradykinin B1 antagonists: SAR studies in the 2,3-diaminopyridine series.EBI Merck
15837330 16 2,3-Diaminopyridine as a platform for designing structurally unique nonpeptide bradykinin B1 receptor antagonists.EBI Merck Research Laboratories
15588075 33 2,3-diaminopyridine bradykinin B1 receptor antagonists.EBI Merck Research Laboratories
15546726 22 Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studies.EBI Merck Research Laboratories
15341478 13 Potent and orally bioavailable non-peptide antagonists at the human bradykinin B(1) receptor based on a 2-alkylamino-5-sulfamoylbenzamide core.EBI TBA
10882365 4 A rational approach to the design and synthesis of a new bradykinin B(1) receptor antagonist.EBI Universités Montpellier I et II
10882364 19 Synthesis and biological evaluation of bradykinin B(1)/B(2) and selective B(1) receptor antagonists.EBI Universités Montpellier I et II
26469307 7 Phosphorylation of Capsaicinoid Derivatives Provides Highly Potent and Selective Inhibitors of the Transcription Factor STAT5b.BDB University of Leipzig